Keywords
Last Name
Institution

Funding Agency: Eli Lilly & Company
Title: Effect of Lilly pharmaceutical compounds on myeloma bone disease and tumor growth in the SCID-rab model
Total direct costs: $50,779
Start Date: 2012-12-15


Collapse Overview 
Collapse researcher role of